Ligand validation:6K6K

RET: RETINAL

RET is a Ligand Of Interest in 6K6K designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6K6K_RET_A_303	68%	75%	0.113	0.924	0.68	0.32	1	-	1	0	100%	0.9524
6XL3_RET_A_301	84%	71%	0.109	0.972	0.63	0.49	1	-	1	0	100%	0.9524
6K6I_RET_A_301	64%	2%	0.133	0.933	4.71	2	13	8	2	0	100%	0.9524
6WP8_RET_A_301	46%	40%	0.203	0.939	0.65	1.65	-	6	1	0	100%	0.9524
6K6J_RET_A_301	41%	2%	0.195	0.911	4.94	1.77	13	10	0	0	100%	0.9524
4OV0_RET_A_301	100%	8%	0.027	0.992	0.76	3.77	-	15	4	0	100%	0.9524
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	0.9524
3UTX_RET_B_301	100%	6%	0.042	0.988	2.42	2.7	5	12	4	0	100%	0.9524
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
5G28_RET_A_1268	97%	23%	0.051	0.968	1.29	1.84	3	5	0	0	100%	0.9524

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.